Treatment of Post-Punch Biopsy Bleeding in Apixaban-Treated Patients Using Self-Administered BXP154B
Status:
COMPLETED
Trial end date:
2024-03-18
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to test if the study drug, BXP154B works to stop bleeding from a minor wound in patients that are on apixaban for anticoagulant therapy. The main questions it aims to answer are:
* How long does it take to stop bleeding after BXP154B is applied to a wound?
* How many people require the use of a rescue treatment to stop bleeding?
* Does BXP154B reduce instances of re-bleeding after the bleeding has stopped initially?
* Is BXP154B safe and well-tolerated?